Delivery Order SPE2DB24D1006-SPE2DB25FCEXV
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.91 to AmerisourceBergen Drug Corp for 7 tablets of Orilissa 150 mg on September 8, 2025, with a completion date of September 9, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a procurement of the endometriosis medication Orilissa to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4569155062, Orilissa 150 mg tablets (quantity 7), valued at $10,086.63 under a firm fixed price contract type. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. No set-aside designation was used for this competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orilissa 150 mg tablets. The $11,137.57 contract has a completion date of May 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Orilissa 200 mg tablets in quantities of 14 units, with a ceiling value of $10,900.19. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and has an ultimate completion date of May 21, 2025. This delivery order represents a child...
- This is a $3,251.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Orilissa 150 mg tablets, a specialty medication. The order has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.24, is for the supply of Orilissa 150 mg tablets. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...